Document is current
Any future updates will be listed below
-
Authors
Palacka, Patrik
Holíčková, Andrea
Roška, Jan
Makovický, Peter
Vallová, Miroslava
Biró, Csaba
Órásová, Eveline
Obertová, Jana
Mardiak, Jozef
Ward, Thomas A.
Kajo, Karol
Chovanec, Miroslav
-
Funding
Funding for this research was provided by:
OncoReSearch
VEGA Agency of the Slovak Republic (2/0075/23)
Integrated infrastructure operational program for the projects 'Systemic public research infrastructure - Biobank for cancer and rare diseases' co-financed by the European Regional Development Fund (313011AFG5)
- License Information
-
More Information
Article History
Received: 22 April 2024
Accepted: 27 August 2024
First Online: 5 September 2024
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the Ethics Review Committee of the SECI (approval number 6-2022/EK, date of approval February 3, 2022) and NCI (approval number UC-SK002/2023, date of approval April 24, 2023). Informed consent was obtained from all study participants.
: Not applicable.
: The authors declare no competing interests.
